Back to Journals » Cancer Management and Research » Volume 10

Letter to the editor “Prognostic value of microRNAs in colorectal cancer: a meta-analysis”

Authors Jayaraj R, Kumarasamy C, Gothandam KM

Received 21 June 2018

Accepted for publication 1 July 2018

Published 13 September 2018 Volume 2018:10 Pages 3501—3503

DOI https://doi.org/10.2147/CMAR.S177875

Checked for plagiarism Yes

Editor who approved publication: Dr Kenan Onel


Rama Jayaraj,1 Chellan Kumarasamy,2 KM Gothandam3

1College of Health and Human Sciences, Charles Darwin University, NT, Australia; 2North Terrace Campus, University of Adelaide, SA, Australia; 3School of Biosciences and Technology, Vellore Institute of Technology, Vellore, Tamil Nadu, India

The systematic review and meta-analyses published by Gao et al1 regarding the topic of microRNAs as prognostic markers in colorectal cancer (CRC) has been of great interest to us. Although previous systematic reviews and meta-analyses highlighting the prognostic value of miRNAs as prognostic markers in CRC exist, each of those studies is primarily focused on a single miRNA per study.2,3 Gao et al,1 via this expansive study, have managed to assess and highlight the prognostic utility of a variety of miRNAs in CRC. Both miR-21 and miR-181 have been highlighted in previous studies as being potential prognostic markers, but interestingly, Gao et al’s1 study is the first to highlight miR-224 and miR-141 as strong prognostic biomarkers, specifically in CRC.

View the original paper by Gao and colleagues.

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF]  View Full Text [HTML][Machine readable]